UPP1: A Protein Regulator of Cell Cycle and Disease (G7378)

Target Name: UPP1

NCBI ID: G7378

UPP1

UPP1: A Protein Regulator of Cell Cycle and Disease

UPP1 (UPase 1) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a key regulator of the cell cycle, and is involved in the separation of the mitotic spindle from the cytoplasm during the process of cell division. UPP1 has also been shown to play a role in a variety of diseases, including cancer, neurodegenerative diseases, and developmental disorders.

One of the key functions of UPP1 is its role in regulating the cell cycle. During the cell cycle, UPP1 helps to maintain the integrity of the mitotic spindle, which is the structure that pulls the chromosomes apart during cell division. The spindle is made up of two tubulin, which are specialized proteins that help to keep the chromosomes in the correct position during the cell cycle. UPP1 helps to ensure that the spindle is properly organized and that the chromosomes are correctly divided.

In addition to its role in regulating the cell cycle, UPP1 has also been shown to play a role in a variety of diseases. For example, UPP1 has been shown to be involved in the development and progression of cancer. In many types of cancer, UPP1 is expressed at higher levels than in healthy cells, and it has been shown to contribute to the development of a variety of cancer-related processes, including the formation of tumors, the growth of cancer cells, and the development of cancer-induced metastasis.

Another area where UPP1 has been shown to be involved in disease is neurodegenerative diseases. UPP1 has been shown to play a role in the development and progression of a variety of neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Huntington's disease. In these conditions , UPP1 is expressed at higher levels than in healthy cells, and it has been shown to contribute to the progression of the disease.

UPP1 has also been shown to be involved in the development and progression of developmental disorders. In many cases, UPP1 is expressed at higher levels in developing organisms than in adult organisms. This has led to the hypothesis that UPP1 plays a role in the development and Progression of a variety of developmental disorders. For example, UPP1 has been shown to be involved in the development and progression of Down syndrome, a genetic disorder that affects approximately 20% of the population.

In conclusion, UPP1 is a protein that is involved in a variety of processes in the body, including the regulation of the cell cycle, the development and progression of cancer, neurodegenerative diseases, and developmental disorders. Its role in these processes makes it an attractive target for research into new treatments for a variety of diseases. Further research is needed to fully understand the functions of UPP1 and to develop effective therapies for the treatment of these conditions.

Protein Name: Uridine Phosphorylase 1

Functions: Catalyzes the reversible phosphorylytic cleavage of uridine and deoxyuridine to uracil and ribose- or deoxyribose-1-phosphate (PubMed:7488099). The produced molecules are then utilized as carbon and energy sources or in the rescue of pyrimidine bases for nucleotide synthesis

The "UPP1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about UPP1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets